The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...

Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

The Food and Drug Administration is expected to approve the first new type of drug for schizophrenia in decades. Called KarXT, the medicine appears to be effective, but its main advantage over current ...

The many health benefits of essential oils range from reducing stress to fighting infectious diseases. Find out if using them ...

The U.S. Food and Drug Administration (FDA) passed a critical mandate regarding dense breast tissue. Here's what it means for ...

FDA alerts in gastroenterology over the summer included an approval for a biosimilar for IBD & new indications for nonerosive ...

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...